Trials / Unknown
UnknownNCT06001099
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-II
Gynecological Malignancies Earlystage Detection by Multi-omics Based Liquid Biopsy in Peripheral Blood: a Prospective, Extended Validation Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,935 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is a prospective study aimed to validate the performance of combined multi-omitcs assays for early detection of gynecologic cancers. Biomarkers of cfDNA methylation, ctDNA mutation and blood miRNA markers will be evaluated. The study will enroll approximately 2935 female participants, including participants with gynecologic cancers patients and healthy participants.
Conditions
Timeline
- Start date
- 2023-02-22
- Primary completion
- 2024-06-30
- Completion
- 2024-12-31
- First posted
- 2023-08-21
- Last updated
- 2023-09-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06001099. Inclusion in this directory is not an endorsement.